Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer?

GRACEcast Lung Cancer Video by cancerGRACE - H. Jack West, MD

Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.